Dmitry Popov

Founder at Maxwell Asset Management LLC (Private Equity)

Finance

Health Technology

Profile

Dmitry Popov is the founder and managing partner of Maxwell Asset Management LLC, a private equity firm founded in 2008.
He is currently the Chief Executive Officer of MYR GmbH.

Dmitry Popov active positions

Companies	Position	Start
Maxwell Asset Management LLC (Private Equity) Maxwell Asset Management LLC (Private Equity) Investment ManagersFinance Maxwell Asset Management LLC /Private Equity/ (Maxwell Asset Management) is the private equity and venture capital subsidiary of Maxwell Capital Group LLC. The firm was founded by Dmitry Popov in 2008. It is headquartered in Moscow, Russia with an additional office in Boston, USA.	Founder	01/01/2008
MYR GmbH MYR GmbH BiotechnologyHealth Technology MYR GmbH engages in operating an biotechnology company. It focuses on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company was founded by Joern Moeller and Alexander Alexandrov in 2010 and is headquartered in Bad Homburg, Germany.	Chief Executive Officer	-

All active positions of Dmitry Popov

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dmitry Popov's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Maxwell Asset Management LLC (Private Equity) Maxwell Asset Management LLC (Private Equity) Investment ManagersFinance Maxwell Asset Management LLC /Private Equity/ (Maxwell Asset Management) is the private equity and venture capital subsidiary of Maxwell Capital Group LLC. The firm was founded by Dmitry Popov in 2008. It is headquartered in Moscow, Russia with an additional office in Boston, USA.	Finance
MYR GmbH MYR GmbH BiotechnologyHealth Technology MYR GmbH engages in operating an biotechnology company. It focuses on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company was founded by Joern Moeller and Alexander Alexandrov in 2010 and is headquartered in Bad Homburg, Germany.	Health Technology